Association of the OPRM1 variant rs1799971 (A118G) and clinical manifestations in tramadol poisoned patients: a cross-sectional study.

MLA

Ershad, Ali, et al. “Association of the OPRM1 Variant Rs1799971 (A118G) and Clinical Manifestations in Tramadol Poisoned Patients: A Cross-Sectional Study.” Clinical Toxicology (Philadelphia, Pa.), vol. 62, no. 6, June 2024, pp. 357–63. EBSCOhost, https://doi.org/10.1080/15563650.2024.2366921.

APA

Ershad, A., Shafiee Dolat Abadi, S., Ebrahimian, M., Hadeiy, S. K., Zamani, N., Kolahi, A.-A., Movafagh, A., & Hassanian-Moghaddam, H. (2024). Association of the OPRM1 variant rs1799971 (A118G) and clinical manifestations in tramadol poisoned patients: a cross-sectional study. Clinical Toxicology (Philadelphia, Pa.), 62(6), 357–363. https://doi.org/10.1080/15563650.2024.2366921

Chicago

Ershad, Ali, Sahel Shafiee Dolat Abadi, Melika Ebrahimian, Seyed Kaveh Hadeiy, Naghmeh Zamani, Ali-Asghar Kolahi, Abolfazl Movafagh, and Hossein Hassanian-Moghaddam. 2024. “Association of the OPRM1 Variant Rs1799971 (A118G) and Clinical Manifestations in Tramadol Poisoned Patients: A Cross-Sectional Study.” Clinical Toxicology (Philadelphia, Pa.) 62 (6): 357–63. doi:10.1080/15563650.2024.2366921.